While details of financial terms were not disclosed by the companies, a report from Axios pegged the deal at “well north of $1 billion.”

Radiology is facing increased regulatory pressure, underlining the need to improve how it interacts with members of this patient community. 

Buzzworthy developments of the past few days.

Part B suppliers experiencing claims disruptions due to the cyberattack can apply to the agency for potential relief. 

The decrease in duration allows for more examinations in the same timeframe, enhances patient comfort and reduces the chance of image distortion. 

Defense attorneys say the case boils down to challenges reading the exam, which was “complex with subtle findings that the experts simply interpreted differently.” 

Years will pass before the global economy’s healthcare sector sufficiently leverages AI to build major financial muscle off of it. And even then, industry players are likely to see gains well ahead of hospitals and health systems. 

Use of Lumisight in conjunction with the Lumicell fluorescent imaging system was found to be safe and effectively guide breast cancer surgeries.